ASHINGTON — Two weeks ago, Dr. Joseph Gulfo ran a panel at the Biotech Showcase in San Francisco titled, “The Trump Administration: What to expect from the FDA.”

He left out one key detail: He may end up running the place.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Gulfo would be a terrific choice. He’s knowledgeable, has long experience in both academic and industry, and has the fire in the belly for reform.

  • What is his position on device approvals and safety? Would he keep the current outdated “one type fits all” system, or move to a framework for Precision Devices, with prescreening patients for immune reactivity to determine if device materials are “right for you” before being installed?

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.